CNTX Earnings Context Therapeutics Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Net income
ROE
Quarterly results
EPS
Net income
ROE
Reported EPS history
1–24 of 24
| Q2 2026 | 2026-06-30 | -0.24 | 2026-08-05 | 10-Q |
| Q1 2026 | 2026-03-31 | -0.09 | 2026-05-06 | 10-Q |
| FY 2025 | 2025-12-31 | -0.38 | 2026-03-23 | 10-K |
| Q3 2025 | 2025-09-30 | -0.24 | 2025-11-05 | 10-Q |
| Q2 2026 | 2025-06-30 | -0.14 | 2026-08-05 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.05 | 2026-05-06 | 10-Q |
| FY 2025 | 2024-12-31 | -0.46 | 2026-03-23 | 10-K |
| Q3 2025 | 2024-09-30 | -0.46 | 2025-11-05 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.17 | 2025-08-06 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.23 | 2025-05-07 | 10-Q |
| FY 2024 | 2023-12-31 | -1.50 | 2025-03-20 | 10-K |
| Q3 2024 | 2023-09-30 | -1.08 | 2024-11-06 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.71 | 2024-08-07 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.40 | 2024-05-08 | 10-Q |
| FY 2023 | 2022-12-31 | -0.93 | 2024-03-21 | 10-K |
| Q3 2023 | 2022-09-30 | -0.71 | 2023-11-09 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.47 | 2023-08-09 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.22 | 2023-05-10 | 10-Q |
| FY 2022 | 2021-12-31 | -3.69 | 2023-03-22 | 10-K |
| Q3 2022 | 2021-09-30 | -20.74 | 2022-11-09 | 10-Q |
| Q2 2022 | 2021-06-30 | -16.82 | 2022-08-11 | 10-Q |
| Q1 2022 | 2021-03-31 | -2.55 | 2022-05-11 | 10-Q |
| FY 2021 | 2020-12-31 | -3.96 | 2022-03-23 | 10-K |
| Q3 2021 | 2020-09-30 | -3.35 | 2021-12-02 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.